Home » Topics » BioWorld Science

BioWorld Science
RSS

Strategy elicits broad immunity against respiratory viruses

Dec. 1, 2021

Tau is involved in the pathogenesis of ALS

Dec. 1, 2021

Jemincare licenses JMKX-1899 ex-China rights to Huyabio

Dec. 1, 2021

Locanabio AAV9 gene therapy constructs show promise for myotonic dystrophy type 1

Dec. 1, 2021

ImmunoPrecise Antibodies advances development of PolyTope for SARS-CoV-2

Dec. 1, 2021

Resolvin D2 for treating Duchenne muscular dystrophy

Dec. 1, 2021

Arbutus Biopharma synthesizes new HBV and HDV antivirals

Dec. 1, 2021

Orion identifies new CYP11A1 inhibitors

Dec. 1, 2021

Quretech Bio presents compounds for Gram-positive bacterial infections

Dec. 1, 2021

Roche patents new GABRA5 PAMs

Dec. 1, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Medtronic bolsters pain portfolio in $650M SPR Therapeutics buy
BioWorld
Medtronic plc is strengthening its pain management portfolio with its $650 million move to buy SPR Therapeutics Inc. and bring the company’s peripheral nerve...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
BMS-Hengrui deal strikes panic in Washington
BioWorld
On the heels of the multibillion-dollar licensing deal between Bristol Myers Squibb Co. and Jiangsu Hengrui Pharmaceuticals Co. Ltd., Chairman John Moolenaar...